相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Concentrations of unbound bevacizumab in the aqueous of untreated fellow eyes after a single intravitreal injection in humans
Carsten H. Meyer et al.
ACTA OPHTHALMOLOGICA (2012)
Age-related macular degeneration
Laurence S. Lim et al.
LANCET (2012)
The Expanding Role of Vascular Endothelial Growth Factor Inhibitors in Ophthalmology
Michael W. Stewart
MAYO CLINIC PROCEEDINGS (2012)
Pharmacotherapy for Neovascular Age-Related Macular Degeneration: An Analysis of the 100% 2008 Medicare Fee-For-Service Part B Claims File
Ross J. Brechner et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
INTRAOCULAR PHARMACOKINETICS AFTER A SINGLE INTRAVITREAL INJECTION OF 1.5 MG VERSUS 3.0 MG OF BEVACIZUMAB IN HUMANS
Carsten H. Meyer et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Pharmacokinetics of intravitreal bevacizumab (Avastin (R)) in rabbits
Christos I. Sinapis et al.
CLINICAL OPHTHALMOLOGY (2011)
Corneal Penetration of Topical and Subconjunctival Bevacizumab
Mohammad H. Dastjerdi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
PET/CT Imaging of I-124-Radiolabeled Bevacizumab and Ranibizumab after Intravitreal Injection in a Rabbit Model
John B. Christoforidis et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Aqueous Humor Concentration of Bevacizumab After Subconjunctival Injection in Rabbit
Moon Jung Kim et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2010)
Topical Bevacizumab in the Treatment of Corneal Neovascularization
Mohammad H. Dastjerdi et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Short- and long-term safety profile and efficacy of topical bevacizumab (AvastinA®) eye drops against corneal neovascularization
Yanyan Koenig et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2009)
Safety Profile of Topical VEGF Neutralization at the Cornea
Felix Bock et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Bevacizumab Application Delays Epithelial Healing in Rabbit Cornea
Tae-im Kim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Pharmacokinetics of Bevacizumab after Topical, Subconjunctival, and Intravitreal Administration in Rabbits
Hiroyuki Nomoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Topical bevacizumab and ocular surface neovascularization in patients with Stevens-Johnson syndrome
Harvey S. Uy et al.
CORNEA (2008)
The Effect of Topical Bevacizumab on Corneal Neovascularization
Sang Woo Kim et al.
OPHTHALMOLOGY (2008)
Vitreous levels of bevackumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
Qi Zhu et al.
OPHTHALMOLOGY (2008)
Mapping of the neonatal Fc receptor in the rodent eye
Hyuncheol Kim et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Bevacizumab (Avastin) for diabetic macular edema in previously vitrectomized eyes
Ates Yanyali et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2007)
Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin)
Roberta P. A. Manzano et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis
Felix Bock et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Pharmacokinetics of intravitreal bevackumab (avastin)
Sophie J. Bakri et al.
OPHTHALMOLOGY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients
Paul M. Beer et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration
Richard F. Spaide et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Influence of format on in vitro penetration of antibody fragments through porcine cornea
HM Brereton et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and nonvitrectomized eyes
HS Chin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2005)
Preclinical pharmacokinetics of ranibizumab (rhuFabV2) after a single intravitreal administration
J Gaudreault et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection
PM Beer et al.
OPHTHALMOLOGY (2003)
分享论文
